Lactulose Sandoz Ltd (Lactulose)

Lactulose is a synthetic sugar that reaches the colon unchanged. There, gut bacteria break it down into short‑chain fatty acids, which lower the pH and create an osmotic pull that draws water into the bowel, softening stool. The acidic environment also converts ammonia to ammonium, trapping it for excretion and reducing systemic ammonia levels.

The dose of Lactulose is individualized and set by the prescribing healthcare professional based on the patient’s condition, severity of constipation or hepatic encephalopathy, response to therapy, and tolerability. Patients should follow the prescriber’s instructions and not adjust the dose on their own.

Safety data for Lactulose in pregnancy and lactation are limited. It is generally considered low risk because it is poorly absorbed, but the decision to use it should be made by the prescriber after weighing potential benefits against any unknown risks to the fetus or infant.

To order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Lactulose is an osmotic laxative that works by increasing water content in the colon, whereas stimulant laxatives such as bisacodyl act by stimulating intestinal motility. Compared with bulk‑forming agents, Lactulose provides a quicker softening effect and also offers the added benefit of reducing ammonia in liver disease.

Lactulose should be stored at room temperature, below 25 °C, in its original container. Keep it away from moisture and direct sunlight. Ensure the container is tightly closed to maintain product stability and prevent contamination.

Lactulose is taken orally, usually as a liquid solution. It can be measured with a calibrated dosing device and mixed with water or another beverage if desired. The exact administration instructions, including timing and any dietary considerations, are provided by the prescriber.

Serious risks include severe dehydration, electrolyte disturbances such as low sodium or potassium, and allergic reactions that may present as rash, swelling or breathing difficulty. Patients experiencing these symptoms should seek medical attention promptly.

Lactulose is contraindicated in patients with known hypersensitivity to the product. Caution is advised for individuals with intestinal obstruction, severe renal impairment, or those at high risk for electrolyte imbalance. The prescriber should evaluate each patient’s medical history before initiating therapy.